Steris | STE - Operating Profit

Stock Price
212.11
Daily Change
-3.87 -1.79%
Monthly
-3.57%
Yearly
-15.69%
Q2 Forecast
207.85

Steris reported $318.7M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
3M USD 1.55B 337M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
CONMED USD 25.42M 11.21M Mar/2026
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Ecolab USD 679.7M 106.9M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fortive USD 191.7M 33.8M Mar/2026
Getinge SEK 1.08B 900M Dec/2024
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Olympus JPY 26.87B 1.14B Mar/2026
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026